Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-05-29

FDA Approved: HALOPERIDOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for HALOPERIDOL LACTATE from Hikma Pharmaceuticals USA Inc., under the ANDA framework.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL LACTATE (HALOPERIDOL)

Snippet

SUPPL AP for HALOPERIDOL (HALOPERIDOL LACTATE)